Seeking Alpha

Intercept Pharma EPS of $1.51

Intercept Pharma (NASDAQ:ICPT): Q2 EPS of $1.51 may not be comparable to consensus of -$0.12.

Revenue of $0.45M (+9.8% Y/Y) beats by $0.05M.

Shares +0.8%.

Press Release

From other sites
Comments (3)
  • StarJonestown
    , contributor
    Comments (33) | Send Message
    Shares are now up $114, 48%
    11 Aug 2014, 04:42 PM Reply Like
  • Hoang6
    , contributor
    Comments (357) | Send Message
    A ~$5B company with only $0.45M in revenue/quarter? That's kinda lame IMO!
    11 Aug 2014, 05:21 PM Reply Like
  • Mongoose7916
    , contributor
    Comments (232) | Send Message
    Haven't really followed ICPT but the numbers don't seem believable. Would anyone who follows this care to explain the huge gap between revenue and earnings so I don't have to read the call later. I imagine it is some kind of one time situation.
    11 Aug 2014, 07:53 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs